NCT01961934View on ClinicalTrials.gov

C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression

PHASE2/PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2018

Conditions
Gliomas
Interventions
DRUG

Sodium Acetate C11 PET/CT Imaging

Trial Locations (1)

85040

Phoenix Molecular Imaging, Phoenix

Sponsors
All Listed Sponsors
lead

Phoenix Molecular Imaging

OTHER

NCT01961934 - C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression | Biotech Hunter | Biotech Hunter